ORIGINAL RESEARCH
Accepted on 19 Jun 2025
Serum GDF15 Level as Predictive Biomarker of Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy
doi 10.3389/fimmu.2025.1619387
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
698
Total downloads
4,441
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 12 Jun 2025
PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy
doi 10.3389/fimmu.2025.1602031
- 403 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression
doi 10.3389/fimmu.2025.1609165
- 457 views
ORIGINAL RESEARCH
Published on 14 Apr 2025
Heterogenous cancer-associated fibroblasts related tumor microenvironment marked by CD10/KLF4/TIAM1 were identified in pancreatic adenocarcinoma by integrated transcriptomics
doi 10.3389/fimmu.2025.1557698
- 2,127 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: